Mike Banville is CEO of ALZpath; a company on a mission to change how we detect Alzheimer’s, earlier and more accessibly. With a career spent leading & growing companies across healthcare and technology, Mike now brings his leadership to a cause that affects millions of families around the world.
In this episode we learn how Mike and his team at ALZpath are making diagnostics more accessible and affordable, potentially transforming the way we approach this dementia. Mike shares insights on the current diagnostics landscape, future prospects, and the importance of democratizing healthcare.
John Ramsay is the Managing Director of Social Ability, a company focused on enhancing the quality of life for individuals with cognitive challenges, particularly...
Dr Cecilia Chan has been involved in the eldercare industry for the past 20 years. She is a Gerontologist, a Trainer, a researcher, and...
Prudence Chan is a clinical director, occupational therapist, and dementia care specialist with extensive experience in her field. She contributes as a visiting dementia...
